[podcast] TB drug and other stock-outs are not acceptable if we are to #endTB in Kenya

This Podcast features Peter Ngo’la Owiti, who is on the Executive Committee Board of Stop TB Partnership, and also represents communities on Medicines Patent Pool. He is also the Executive Director of the Wote Youth Development Projects, Kenya.

Listen to his insights on why stock-outs of medicines for drug-sensitive TB, essential needs which are required to refer patients, or of cartridges to run nucleic acid amplification tests (NAAT) molecular diagnostics such as Gene Xpert are not acceptable.

Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, Stitcher, TuneIn, aCast, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, and other podcast streaming platforms.

CNS team